Matches in Wikidata for { <http://www.wikidata.org/entity/Q89817054> ?p ?o ?g. }
- Q89817054 description "2020 nî lūn-bûn" @default.
- Q89817054 description "2020年の論文" @default.
- Q89817054 description "2020年学术文章" @default.
- Q89817054 description "2020年学术文章" @default.
- Q89817054 description "2020年学术文章" @default.
- Q89817054 description "2020年学术文章" @default.
- Q89817054 description "2020年学术文章" @default.
- Q89817054 description "2020年学术文章" @default.
- Q89817054 description "2020年學術文章" @default.
- Q89817054 description "2020年學術文章" @default.
- Q89817054 description "2020年學術文章" @default.
- Q89817054 description "2020年學術文章" @default.
- Q89817054 description "2020年學術文章" @default.
- Q89817054 description "2020년 논문" @default.
- Q89817054 description "article científic" @default.
- Q89817054 description "article scientific" @default.
- Q89817054 description "article scientifique" @default.
- Q89817054 description "articol științific" @default.
- Q89817054 description "articolo scientifico" @default.
- Q89817054 description "artigo científico" @default.
- Q89817054 description "artigo científico" @default.
- Q89817054 description "artigo científico" @default.
- Q89817054 description "artikel ilmiah" @default.
- Q89817054 description "artikull shkencor" @default.
- Q89817054 description "artikulong pang-agham" @default.
- Q89817054 description "artykuł naukowy" @default.
- Q89817054 description "artículo científico publicado en 2020" @default.
- Q89817054 description "artículu científicu" @default.
- Q89817054 description "bilimsel makale" @default.
- Q89817054 description "bài báo khoa học" @default.
- Q89817054 description "naučni članak" @default.
- Q89817054 description "scienca artikolo" @default.
- Q89817054 description "scientific article published on 18 February 2020" @default.
- Q89817054 description "scientific article published on 18 February 2020" @default.
- Q89817054 description "scientific article published on 18 February 2020" @default.
- Q89817054 description "teaduslik artikkel" @default.
- Q89817054 description "tieteellinen artikkeli" @default.
- Q89817054 description "tudományos cikk" @default.
- Q89817054 description "vedecký článok" @default.
- Q89817054 description "vetenskaplig artikel" @default.
- Q89817054 description "videnskabelig artikel udgivet 18. februar 2020" @default.
- Q89817054 description "vitenskapelig artikkel" @default.
- Q89817054 description "vitskapeleg artikkel" @default.
- Q89817054 description "vědecký článek" @default.
- Q89817054 description "wetenschappelijk artikel" @default.
- Q89817054 description "wissenschaftlicher Artikel" @default.
- Q89817054 description "επιστημονικό άρθρο" @default.
- Q89817054 description "мақолаи илмӣ" @default.
- Q89817054 description "наукова стаття, опублікована в лютому 2020" @default.
- Q89817054 description "научна статия" @default.
- Q89817054 description "научная статья" @default.
- Q89817054 description "научни чланак" @default.
- Q89817054 description "научни чланак" @default.
- Q89817054 description "מאמר מדעי" @default.
- Q89817054 description "مقالة علمية نشرت في 18 فبراير 2020" @default.
- Q89817054 description "১৮ ফেব্রুয়ারি ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q89817054 description "บทความทางวิทยาศาสตร์" @default.
- Q89817054 description "სამეცნიერო სტატია" @default.
- Q89817054 name "Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer" @default.
- Q89817054 name "Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer" @default.
- Q89817054 type Item @default.
- Q89817054 label "Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer" @default.
- Q89817054 label "Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer" @default.
- Q89817054 prefLabel "Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer" @default.
- Q89817054 prefLabel "Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer" @default.
- Q89817054 P1433 Q89817054-7C97D8B5-BD8E-45EA-ABA0-3CB24B5BA53F @default.
- Q89817054 P1476 Q89817054-8A98F72C-DF64-44FE-B6AB-9B64CED91578 @default.
- Q89817054 P2093 Q89817054-07ED5636-D753-45FF-B70B-34E1A8EF2DB9 @default.
- Q89817054 P2093 Q89817054-0CA9DB3B-6D1E-4628-8566-FE8DFE1C9130 @default.
- Q89817054 P2093 Q89817054-0F7C8A15-DEF3-42C8-8B56-DE156AEB35C8 @default.
- Q89817054 P2093 Q89817054-48337CF1-78F6-40C2-B875-61AFF5547E6A @default.
- Q89817054 P2093 Q89817054-4ED48B51-BD84-41D7-BCB1-26CDB1C3F15B @default.
- Q89817054 P2093 Q89817054-654CB759-9012-42D7-991C-B02D064CC1D6 @default.
- Q89817054 P2093 Q89817054-68412CE2-FF75-47D3-B635-5857FAB3E1BA @default.
- Q89817054 P2093 Q89817054-BD4C1770-272F-45EB-95C6-7A13D2768FBD @default.
- Q89817054 P2093 Q89817054-DC29072D-BB58-4CE8-B6B3-245717F08295 @default.
- Q89817054 P2093 Q89817054-EA801C6F-FF74-4716-BB77-D41177C5DA10 @default.
- Q89817054 P2860 Q89817054-05A40C8F-FDBB-408B-BF08-E26FC4EDF8E9 @default.
- Q89817054 P2860 Q89817054-12B972F4-DC88-4ECB-A2FA-2BF3ECDD031D @default.
- Q89817054 P2860 Q89817054-1681F7BE-E8C3-4D7F-861A-AF9FD359C317 @default.
- Q89817054 P2860 Q89817054-18CBCDB4-197C-47F3-A4D7-6DFB1E914406 @default.
- Q89817054 P2860 Q89817054-18EF4A0B-90A0-4B30-A7D0-A34F034D291F @default.
- Q89817054 P2860 Q89817054-32288180-0933-4E34-92BD-A7AA7A0F5B94 @default.
- Q89817054 P2860 Q89817054-4752D55A-9AD1-45F0-8AA4-9BBBE932CD7A @default.
- Q89817054 P2860 Q89817054-4BD49A70-4547-4F82-A586-2C493B50892B @default.
- Q89817054 P2860 Q89817054-4CF16646-C1F9-464C-82D8-52FFB105A89A @default.
- Q89817054 P2860 Q89817054-644F2697-7ED6-40C0-9063-E69CF3ECE79F @default.
- Q89817054 P2860 Q89817054-66100C0C-8F45-4408-96C4-D2A4832BF19C @default.
- Q89817054 P2860 Q89817054-67D4E356-15A8-48E5-8547-BD79DC8739D0 @default.
- Q89817054 P2860 Q89817054-683F1822-0324-49E7-AFCA-1C6196042709 @default.
- Q89817054 P2860 Q89817054-7DE4DBEF-CAF4-489E-9C03-6EEE192ACB24 @default.
- Q89817054 P2860 Q89817054-7F953832-FAEC-4117-AD4A-F456618876F4 @default.
- Q89817054 P2860 Q89817054-83C94720-35A9-498F-90BF-9006316D845C @default.
- Q89817054 P2860 Q89817054-9005AAFB-4554-4199-9BC2-ADE70CA462CD @default.
- Q89817054 P2860 Q89817054-A87EB0E4-7845-4AA9-8531-A024292EE581 @default.
- Q89817054 P2860 Q89817054-A8C8017C-9228-4A54-8ED5-D1BD3F1BF13B @default.
- Q89817054 P2860 Q89817054-ACD844BC-B2F9-4560-99D2-C31F559F52BF @default.
- Q89817054 P2860 Q89817054-AEA2961F-2AE2-4A46-9142-FC9581988551 @default.
- Q89817054 P2860 Q89817054-AFBEB96E-1215-4A7F-832D-59C8B3495B4C @default.
- Q89817054 P2860 Q89817054-B09C8964-9377-476A-946F-20EBE355D683 @default.